Click Below to Return to Drug Transparency Home Page:
Subscribe/Unsubscribe to LISTSERV email notifications for Nevada Drug Transparency Information and Updates Here:
Drug Tranparency - Essential Lists, Reports & Resources
List of Essential Drugs for Treating Diabetes ~ SB 539 Section 3.6 & NRS 439B.630
Drug Pricing Report ~ SB 539 Section 4.3 & NRS 439B.635
Senate Bill No. 539 was passed during the 2017 legislative session, requiring the Department to analyze the information submitted pursuant to sections 3.8, 4 and 4.2 of this act and compile a report on the price of the prescription drugs that appear on the most current lists compiled by the Department pursant to section 3.6 of this act, the reasons for any increase in those prices and the effect of those prices on overall spending on prescription drugs in the State. The report may include, without limitation, opportunities for persons and entities in this State to lower the cost of drugs for the treatment of diabetes while maintaining access to such drugs.
Pharmaceutical Sales Representatives Report ~ SB 539 Section 4.6(5) & NRS 439B.660
Drug Transparency Regulations ~ SB 539 & NRS 439B